Elsevier

Nutrition

Volume 78, October 2020, 110863
Nutrition

Basic nutritional investigation
Probiotic Lactobacillus rhamnosus GG reduces mortality of septic mice by modulating gut microbiota composition and metabolic profiles

https://doi.org/10.1016/j.nut.2020.110863Get rights and content

Highlights

  • Lactobacillus rhamnosus GG (LGG) supplementation may be able to reduce sepsis-induced mortality.

  • LGG treatment is more likely to alter the bacterial and short-chain fatty acid composition related to sepsis.

  • LGG can mitigate sepsis partly through reversing colon metabolic abnormalities.

  • Host co-microbiota and metabolism played an important role in LGG therapy in sepsis.

Abstract

Objective

The use of probiotics to reduce mortality of sepsis was supported by a series of clinical research subjects. However, the exact mechanisms underlying protective effects of probiotic in sepsis has not been elucidated clearly. The aim of this study was to explore the therapeutic effects of Lactobacillus rhamnosus GG (LGG) prophylaxis on the host co-microbiota and metabolism in mice with sepsis-induced colon microbiota dysbiosis.

Methods

Mice were fed either probiotic LGG or saline 4 wk before cecum ligation and puncture (CLP) operation. Fecal samples were collected and analyzed by 16S rDNA sequencing and ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS)–based metabolomics.

Results

LGG treatment could noticeably reduce the mortality of sepsis and reverse gut microbiota dysbiosis caused by sepsis. Specifically, LGG reduced conditional pathogenic bacteria, such as Proteobactria and Deferribacteres; lipopolysaccharide producers like Enterobacteriaceae, facultative anaerobes, including Bacteroidaceae and Erysipelotrichaceae, and increased the abundance of bacteria related to energy harvest, such as Firmicutes; colon barrier restorers like Akkermansia; and liver function regulators like Coprococcus and Sutterella. Furthermore, the changes in fecal metabolites were prevented by LGG. These changes were found mainly to be correlated with the bile acid and metabolism pathways, lysophosphatidylcholines metabolism, and eicosatetraenoic acid metabolism. Finally, correlation analysis shown that microbiota dysbiosis was closely related to metabolic imbalance.

Conclusions

Probiotic LGG may has a positive effect on reducing mortality of sepsis through rebalancing the metabolic profiles and gut microbiota.

Introduction

Sepsis is considered a severe systemic infection triggered by a pathogenic organism [1]. Although current therapies like fluid resuscitation, antibiotics to ameliorate symptoms, and organ protection, there is no cure for this disease [2]. Therefore, the need for sensitive diagnostic techniques and new therapies for sepsis is compelling. Emerging evidence suggests that intestinal epithelial barrier disturbed and breached by sepsis-promoting bacteria escape to the blood, which results in an aggravation of sepsis [3]. Numerous studies have indicated that both richness and diversity of the microbiota in patients with sepsis are different from those of healthy controls [4,5], and probiotic treatment during sepsis is helpful to reduce the mortality induced by disease progression [6,7]. However, the exact effects and the mechanisms involved in probiotic application remain obscure.

At present, based on intestinal microbiota and metabolism analysis, the combination of 16 S ribosomal DNA gene sequencing and untargeted metabolomics technology is becoming a useful method for revealing the underlying mechanism(s) of diseases or treatments of diseases [8]. The 16 S rDNA gene sequencing technology can rapidly and accurately decipher microbiota profile and reveal the alteration of structure of the gut microbiota associated with diseases and different treatments [9]. Metabonomics, an important technology that provides a global metabolic profile of biological samples, detects metabolism changes caused by internal or external stimuli such as disease progression, pathophysiologic status, or drug treatments [10]. In this research, a 16 S rDNA gene sequencing technology and an ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS) technology were combined to explore the therapeutic effects of LGG prophylaxis on the host co-microbiota and metabolism in mice with sepsis-induced colon microbiota dysbiosis.

Section snippets

Ethics statement

Male C57 BL6 mice (4 wk old) were purchased from Zhejiang University. The animal experiments were approved by the Animal Experiments Committee of the First Affiliated Hospital, Zhejiang University. Mice were given a standard mouse chow diet and sterile water under pathogen-free conditions.

Reagents and materials

Probiotic LGG (containing 20 × 1010 colony-forming unit (CFU) of live bacteria per capsule) were purchased from Culturelle corporation (ConAgra Foods, Omaha, NE, USA). Acetonitrile, formic acid, and

LGG prophylaxis reduces mortality and bacteremia in septic mice

Our formal research found that LGG prophylaxis was able to improve 7-d survival rate of septic mice (P = 0.029) [12]. There was no significant difference in total mortality between control and LGG-pretreated septic mice; however, the average days until death in LGG prophylaxis septic mice was significantly elevated (P < 0.05; Supplementary Table 1).

To test whether probiotic LGG can alleviate sepsis-induced bacteremia, we cultured the peripheral blood of mice in different treatment groups a 24 h

Discussion

Sepsis and its treatment lead to an adverse gastrointestinal microenvironment [13]. Administration of Lactobacilli was able to induce modifications in human gastrointestinal microbial ecosystem and therefore became a potential therapeutic approach in treatment of several diseases including sepsis [14], [15], [16]. However, few studies have indicated the potential risk for bacteremia after the administration of probiotic [17]. Thus, great care is required in choosing the proper species of

Conclusions

To our knowledge, this was the first study in which a 16 S rDNA gene sequencing technology and an UPLC-QTOF-MS technology were combined to explore the positive effect of LGG on sepsis. We found that prophylactic LGG treatment is able to reduce mortality through rebalancing the colon microbiome and host metabolism in septic mice. Septic mice had higher levels of secondary BA and lower levels of primary BA than LGG-treated mice. LGG alter the composition of bacteria related to BA metabolism, and

Acknowledgments

The authors acknowledge the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Medical College, Zhejiang University for their support in 16 S rDNA sequence analysis and UPLC-QTOF-MS manipulation.

References (31)

  • C Wang et al.

    Microbiota-immune interaction in the pathogenesis of gut-derived infection

    Front Immunol

    (2019)
  • Liu Z, Li N, Fang H, Chen X, Guo Y, Gong S, et al. Enteric dysbiosis is associated with sepsis in patients. FASEB J...
  • V Stadlbauer et al.

    Dysbiosis in early sepsis can be modulated by a multispecies probiotic: a randomised controlled pilot trial

    Benef Microbes

    (2019)
  • BW Haak et al.

    Therapeutic potential of the gut microbiota in the prevention and treatment of sepsis

    Front Immunol

    (2018)
  • A Zarrinpar et al.

    Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signalingand colonic metabolism

    Nat Commun

    (2018)
  • Cited by (33)

    • Effect of fructooligosaccharides on the colonization of Lactobacillus rhamnosus AS 1.2466<sup>T</sup> in the gut of mice

      2023, Food Science and Human Wellness
      Citation Excerpt :

      The results of the study show that L. rhamnosus AS 1.2466T can accelerate the relative abundance of Lactobacillus and Akkermansia, while inhibiting the proliferation of Klebsiella, thereby regulating the gut microbiota. FOS could change the micro-ecological environment in the gut [18]. The combination of 2 × 109 L. rhamnosus AS 1.2466T and 3.99 g/kg bw FOS can prolong the colonization time of L. rhamnosus AS 1.2466T in the intestine and increase the colonization time of L. rhamnosus AS 1.2466T number.

    • Application of metabolomics analysis to aid in understanding the pathogenicity of different lineages and different serotypes of Listeria monocytogenes

      2022, International Journal of Food Microbiology
      Citation Excerpt :

      Concisely, differential metabolites were screened according to the output VIP value of the established OPLS-DA model and the statistical value of significance (P value). The differential metabolites screening parameters were VIP ≥ 1.5 and P < 0.05 (Chen et al., 2020; Höcker et al., 2021; Rivera-Pérez et al., 2021). The Formula Finder plug-in in the PeakView 2.2 software (AB SCIEX) was used to screen for potential differential characteristic ions.

    • Lacticaseibacillus rhamnosus modulates the inflammatory response and the subsequent lung damage in a murine model of acute lung inflammation

      2022, Clinics
      Citation Excerpt :

      In addition, probiotics can enhance immune activity, decrease the occurrence of nosocomial pneumonia and multiple organ dysfunction syndromes, and reduce days in the hospital.46 These results corroborate findings that show a decrease in sepsis incidence, to improve sepsis outcome, and to decrease late mortality after sepsis.33 Despite the beneficial effect of probiotics after ALI, it is important to highlight that regimen of previous treatment creates an anti-inflammatory lung milieu, and this condition can alleviate inflammatory response in the presence of sepsis.

    • Chitooligosaccahrides: Digestion characterization and effect of the degree of polymerization on gut microorganisms to manage the metabolome functional diversity in vitro

      2022, Carbohydrate Polymers
      Citation Excerpt :

      Biomarkers with statistically different abundance in treatment groups were screened at the genus and species levels (Fig. 6). As the monomer form of COS, GlcN mainly promotes the abundance of Lactobacillus rhamnosus (acetic and indole lactic acid producing-bacteria), and this strain is related to bile acid metabolism and eicosatetraenoic acid metabolism (Chen, Li, et al., 2020). The biomarkers of the COS2 and COS3 groups were similar: the core microbial community was composed of Clostridium butyricum, Clostridium, and Parabacteroides, which mainly produced butyrate.

    View all citing articles on Scopus

    This work was supported by the National Natural Science Foundation of China (grant no: 81771498) and Zhejiang Traditional Chinese Medicine Administration (grant no: 2017-XK-A31). LC participated in the conceptualization and methodology of the study; the software, writing of the original draft, and reviewing and editing the final version. HL participated in the study methodology and formal analysis. YC participated in the visualization. YY participated in the supervision and funding acquisition.

    View full text